Dose Dense Chemotherapy Regimen Improves Survival In Breast Cancer
Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer
Arimidex Continues To Show Improvement Over Tamoxifen
Iressa May Benefit Some Breast Cancer, Studies Find
Gleevec Improves Survival Of CML In Accelerated Phase
Phase II Study Tests Chemo Plus Mylotarg For AML
“Proof Of Concept” Shown In Early Trial Of PKC-412
Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis
Clinical Trials Approved By NCI During November Are Listed
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment
